Zacks Investment Research on MSN

JNJ vs. PFE: Which blue-chip drug stock is the better investment now?

Johnson & Johnson JNJ and Pfizer PFE are both healthcare leaders with large drug portfolios and diversified revenue streams, ...
New Orleans City Business

Pfizer strikes drug pricing deal with Trump

Drugmaker Pfizer has agreed to lower drug costs under a deal struck with the Trump administration, President Donald Trump said Tuesday, as he promised similar deals will be struck with other ...
Zacks Investment Research on MSN

Pfizer's Cancer Drugs Deliver Growth Amid Competitive Pressure

Pfizer PFE is one of the largest and most successful drugmakers in oncology. It boasts a strong portfolio of approved cancer ...
Virginia Business

Pfizer agrees to lower drug costs, $70B US investment

WASHINGTON (AP) — Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration, President Donald Trump said Tuesday.
BioSpace

Pfizer Builds Case for Tukysa as ‘New Standard Regimen’ in First-Line Metastatic Breast Cancer

While new late-stage data point to some liver toxicity signals, analysts at BMO Capital Markets said Tukysa’s efficacy ...

Health Rounds: Pfizer drug delays progression of advanced breast cancer in trial

Pfizer’s Tukysa added to maintenance therapy significantly delayed disease progression in patients with HER2-positive ...
WDIO

New drug price deal with Pfizer announced

On Tuesday, President Donald Trump, health leaders and the CEO of Pfizer announced a new drug pricing deal. The announcement, which Trump made with Pfizer CEO Albert Bourla at the White House, came as ...
Fierce Pharma

Pfizer's Tukysa delays HER2 breast cancer progression as 1st-line maintenance therapy

Pfizer has rolled out detailed trial data suggesting Tukysa could be part of a new first-line treatment to delay the progression of HER2-positive breast cancer. | Pfizer has rolled out detailed trial ...
newscase

Pfizer Stock: A Contrarian Bet Amidst Market Uncertainty

The investment case for pharmaceutical giant Pfizer is presenting a complex puzzle. Conflicting signals are creating a stark ...
6abc News

Pfizer agrees to lower prescription drug costs for Medicaid in deal with President Donald Trump

WASHINGTON -- Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals ...
News9

Pfizer agrees to lower prescription drug costs for Medicaid in deal with Trump

Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other ...
KTBS

Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump

WASHINGTON – Drugmaker Pfizer has agreed to lower drug costs under a deal struck with the Trump administration, President Donald Trump announced Tuesday at the White House alongside Pfizer CEO Albert ...